Symptom Management Implementation of Patient Reported Outcomes in Oncology
Completed · Not applicable
Conditions studied: Other Cancer, Gastrointestinal Cancer, Thoracic Cancer, Gynecologic Cancer
In brief
Deficits in the management of common symptoms cause substantial morbidity for cancer patients.Because the health care delivery system is structured to be reactive and not proactive, there are missed opportunities to optimize symptom control. Growth in Internet access and proliferation of smartphones has created an opportunity to re-engineer cancer care delivery. Electronic symptom tracking and feedback is a promising strategy to improve symptom control. Electronic patient reported outcome (ePRO) monitoring of cancer symptoms has been shown to decrease symptom burden, improve quality of life, reduce acute care and even extend survival. SIMPRO will use functioning ePRO prototypes to create and refine the electronic symptom management system eSyM
Key facts
- Study ID
- NCT03850912
- Run by
- Dana-Farber Cancer Institute
- People needed
- 42808
- Starts
- 2019-07-25
- Expected to finish
- 2025-06-09
- Last updated by the study team
- 2025-08-27
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Stakeholder Feedback and Stakeholder Qualitative Interviews Population:
- Age ≥ 18 years
- The potential stakeholders are: patient advisory council members, health system leaders, clinicians, clinic support staff/administration, IT/Informatics staff
- Cluster Randomized Trial, Patient QualitativeInterviews, Pilot Testing \& SASS Questionnaire Population:
- Age ≥ 18 years
- Priority population will be patients who meet one of the following:
- Suspected thoracic cancer [lung or bronchus] AND is inpatient following thoracic surgery.
- Suspected gastrointestinal cancer [colorectal, pancreas, liver/biliary, esophagus,or gastric] AND is inpatient following gastrointestinal surgery.
- Suspected gynecologic cancer [ovary, uterus, or cervix] AND is inpatient following gynecologic surgery.
- Diagnosis of thoracic cancer [lung or bronchus] AND scheduled to start a new treatment plan for thoracic cancer.
- Diagnosis of gastrointestinal cancer [colorectal, pancreas, liver/biliary, esophagus,or gastric] AND scheduled to start a new treatment plan for gastrointestinal cancer.
- Diagnosis of gynecologic cancer [ovary, uterus, or cervix] AND scheduled to start a new treatment plan for gynecologic cancer.
- Total population allowed to use eSyM:
- Any patient at any participating site.
You may not qualify if…
- Participants not meeting the inclusion critera above.
Where it is running
- Maine Medical Center — Portland, Maine, United States
- Dana Farber Cancer Institute — Boston, Massachusetts, United States
- Dartmouth-Hitchcock Medical Center — Lebanon, New Hampshire, United States
- Brown University Health (formerly Lifespan Cancer Institute) — Providence, Rhode Island, United States
- Baptist Memoiral HealthCare — Memphis, Tennessee, United States
- West Virginia University Medical Center — Morgantown, West Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.